2026 Federal Hemp Ban: Understanding the Legislative Paradox Reshaping the Consumable Hemp Market

This article first appeared in the July 2026 issue of Presence Marketing’s newsletter.

By Steven Hoffman

For years, the natural products industry has served as the tip of the spear for plant-based wellness and agricultural innovation. Independent health food stores, natural grocery chains and co-ops were among the first to educate American consumers on the endocannabinoid system. They were the pioneers who brought hemp-derived CBD to the mainstream, championing a botanical remedy that offered millions relief from pain, anxiety and inflammation without the intoxicating effects of traditional marijuana.

Thanks to the 2018 Farm Bill, which legalized commercial hemp cultivation, a vibrant supply chain emerged. From the regenerative organic farmer cultivating the crop to the innovative manufacturer formulating tinctures and topicals, to the retailer curating wellness aisles, the hemp economy blossomed into a formidable market. According to Inc. Magazine, the hemp sector is now valued at a staggering $28.4 billion, supporting more than 300,000 jobs nationwide.

Yet, as we move through the summer of 2026, this thriving ecosystem faces an existential threat. A looming federal ban, passed quietly as a rider in a 2025 appropriations bill, threatens to decimate the consumable hemp market by the end of the year.

At the exact moment the federal government is taking historic steps to deregulate and reschedule marijuana, it is simultaneously moving to criminalize the non-intoxicating, therapeutic hemp products that natural products retailers have safely sold for years. For business owners, executives, and professionals in the natural and organic food market, understanding the mechanics of this ban, the paradox of federal cannabis policy, and the ongoing fight for agricultural seed sovereignty is critical to navigating the turbulent months ahead.

Section 781 and the November 12 Deadline
The crisis stems from the Appropriations Act for 2026, signed into law on Nov. 12, 2025, to end a government shutdown. Buried within the legislation was Section 781, a provision orchestrated largely by Representative Andy Harris (R-MD), who presides over the House Appropriations Subcommittee on Agriculture, and bolstered by the legislative weight of Senator Mitch McConnell (R-KY), that fundamentally redefines legal hemp in the United States.

Under the 2018 Farm Bill, hemp was defined as cannabis containing less than 0.3% delta-9 THC on a dry-weight basis. Beyond the promise of food and fiber products derived from hemp, this definition allowed for the proliferation of full-spectrum CBD products, which naturally contain trace amounts of THC. However, it also created a loophole that allowed chemists to synthesize intoxicating cannabinoids—like delta-8 THC and THCA—from legal hemp CBD, leading to a flood of unregulated, intoxicating products in convenience stores and gas stations across the country.

Rather than creating a robust regulatory framework to address synthetic intoxicants, Congress opted for a blunt instrument. As detailed by Vicente LLP, Section 781 shifts the definition of hemp to a "total THC standard" (0.3% total THC, inclusive of THCA and delta-8). More devastatingly, the law caps final-form hemp-derived cannabinoid products at a microscopic 0.4 milligrams of total THC per container.

Absent intervening legislation, this restrictive standard takes effect on Nov. 12, 2026. Because even non-intoxicating, full-spectrum CBD products naturally contain more than 0.4 milligrams of trace THC per container, the new law essentially throws the baby out with the bathwater. According to the U.S. Hemp Roundtable, the ban will render approximately 95% of existing hemp-derived cannabinoid products federally unlawful.

As Forbes recently noted, the new rules will knock out popular, non-intoxicating CBD products that consumers rely on daily. For natural products retailers, this means that the tinctures, gummies, and functional beverages currently driving significant foot traffic and revenue will likely become contraband overnight. According to Recovered.org, the law will stringently restrict the possession and sale of these products, particularly in states where marijuana remains illegal.

Retailers and Producers Raise the Alarm
The impending ban has sent shockwaves through the natural products supply chain. Retailers who meticulously vetted brands for organic certification, clean extraction methods and third-party testing are now facing the prospect of emptying their shelves of CBD products.

Local businesses and wellness practitioners are raising the alarm, arguing that federal policymakers have fundamentally misunderstood the products they are banning. "We have the backing of medical professionals in Lancaster, in Pennsylvania, and across the country that refer their patients to us for pain relief," Heather Kreider, owner of Hempfield Botanicals in Lancaster, PA, told Fox43. "I'm a registered nurse myself. I'm also a cannabis educator, so I take what we do here very seriously. We're doing the right things here; however, those bad players are not, and they're the ones that are causing the issues."

The collateral damage extends beyond the retail sector and into federal healthcare initiatives. As reported by The Guardian, the hemp ban will effectively derail a highly anticipated Medicare pilot program designed to reimburse seniors for hemp-derived products. The model program, which launched just months ago, covered up to $500 per year for eligible Medicare patients utilizing CBD products. The federal ban undermines this progress entirely, cutting off affordable access to natural wellness for vulnerable populations.

As the Alliance for Natural Health argues, the ban is "built on broken science." By targeting the trace, naturally occurring cannabinoids in full-spectrum hemp, the government is effectively outlawing a botanical medicine that millions of Americans rely upon daily.

The Marijuana Rescheduling Paradox
Perhaps the most bewildering aspect of the 2026 federal hemp ban is the stark policy contradiction it creates within the broader cannabis landscape.

While the federal government is lowering the hammer on non-intoxicating hemp products, it is simultaneously taking historic steps to deregulate traditional, high-THC marijuana. In recent months, federal agencies have moved to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act, recognizing its medical utility and reducing tax burdens for state-licensed dispensaries.

This creates a jarring paradox for grocery retailers and natural food vendors: The federal government is facilitating the growth of the intoxicating, highly regulated dispensary market while actively criminalizing the non-intoxicating hemp market historically sold in mainstream grocery aisles.

Reason magazine recently highlighted this hypocrisy, noting that Mitch McConnell's push for the hemp ban betrays the very industry he helped create through the 2018 Farm Bill. The prohibition destroys a thriving industry to solve a regulatory issue that individual states were already handling effectively.

The backlash against this paradox has prompted unexpected political alliances. In April 2026, President Donald Trump took to Truth Social to push Congress to save the industry. Following his administration's historic moves to protect medical marijuana, Trump stated he was calling on Congress to update the law "to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on ... while preserving Congress’s intent to restrict the sale of products that pose health risks."

Seed Sovereignty: The Hidden Threat of Section 781
While the consumer impact of the hemp ban has dominated the headlines, Section 781 contains a more insidious threat to agriculturalists: the erosion of seed sovereignty.

In the regenerative agriculture and organic farming communities, seed sovereignty—the right of farmers to save, breed, and exchange seeds free from corporate or government overreach—is a sacred tenet. Yet, the new federal definitions deeply compromise this right. As detailed by Grow Weed Easy, the new federal hemp and cannabis seed law dictates that viable seeds from high-THC plants are explicitly excluded from the definition of legal hemp, even if the seeds themselves contain zero THC.

This linguistic shift in the federal code has profound implications. Green State reports that this little-known federal rule could effectively make vast swaths of cannabis seeds illegal, paralyzing the nation's seed banks, agricultural research institutions, and independent farmers. Local businesses are already feeling the chilling effect. In Maine, the Fairfield Hemp Seed Company warned that the federal bill could lead to their closure, stripping farmers of access to reliable, region-specific genetics

Leading the charge against this agricultural overreach is the American Seed Innovation & Genetics Association (ASIGA). In a comprehensive white paper regarding Section 781, ASIGA meticulously outlines how the government's conflation of mature plant cannabinoids with the genetic potential of a seed stifles agricultural innovation.

By criminalizing seeds based on their potential future THC expression rather than on their current chemical makeup, the federal government is erecting massive barriers to entry for independent breeders. ASIGA argues that seeds are the essential foundation of agricultural diversity. Without the legal protection to trade and cultivate diverse cannabis genetics, the industry risks consolidating into the hands of a few well-capitalized, multi-state operators, directly contradicting the anti-monopoly ethos of the natural products industry. For organizations championing seed sovereignty and legal clarity, repealing or amending Section 781 is not just about saving CBD gummies; it is about defending a farmer's fundamental right to the seed.

The Legislative Scramble: Will Congress Intervene?
With the November 12 deadline approaching, the hemp industry has launched a desperate legislative scramble to save itself.

Several lawmakers have attempted to introduce rescue measures. In the House, Rep. James Comer (R-KY) and Rep. Andy Barr (R-KY)  introduced bills and amendments aimed at establishing a comprehensive regulatory framework or delaying the ban entirely. Three U.S. House Republicans recently attempted to thwart the intoxicating hemp product ban during Farm Bill negotiations, and another GOP lawmaker is currently circulating a bill to keep hemp THC drinks federally legal. Furthermore, the intoxicating hemp industry is actively seeking a rescue in Congress.

However, the political reality is grim. Despite bipartisan lobbying efforts, the U.S. Congress has repeatedly blocked the latest rescue attempts. According to Marijuana Moment, top marijuana reform groups concede that Congress is unlikely to prevent the new federal ban this year.

The broader cannabis industry finds itself fractured. Some stakeholders in the licensed marijuana dispensary space view the hemp ban as a victory, eliminating competition from unregulated hemp-derived products. As Hemp Today reports, bipartisan lobbyists have joined the cynical cause as intoxicating hemp faces its endgame, resulting in a situation where the federal axe is finally falling on intoxicating hemp.

Unfortunately, the collateral damage of this infighting is the natural and organic food retailer, the hemp farmer, and the consumer relying on full-spectrum CBD.

How Retailers and Brands Can Prepare
As we stare down the barrel of November 2026, business leaders in the natural products sector must be pragmatic. Hoping for a last-minute congressional miracle is not a viable business strategy.

While the question of which products will disappear under the national hemp ban remains unanswered pending potential enforcement guidance, retailers and manufacturers must audit their supply chains immediately. Brands should consult with legal counsel to understand their exposure to the 0.4-milligram total THC limit per container. Retailers must review their vendor agreements and prepare for significant SKU rationalization in their wellness aisles.

However, as MJBiz Daily astutely points out, hemp THC regulation is inevitable, but it’s not a ban—and operators must prepare. The natural products industry must pivot from reacting to prohibition to actively advocating for intelligent, science-based regulation. This means supporting organizations like ASIGA in the fight for seed sovereignty, and aligning with groups like the U.S. Hemp Roundtable and others to demand strict age restrictions on sales (age-gating), cGMP manufacturing standards, and truthful labeling over outright bans.

The natural products sector is no stranger to navigating complex regulatory shifts, and while retailers will ultimately adapt to the loss or transformation of a popular wellness category, the 2026 Federal Hemp Ban poses a genuine threat to the farmers, formulators, and producers who built the $28 billion consumable hemp products market. Moving forward, the survival of the consumable hemp sector depends not on a return to the unregulated gray market, but on a unified industry push for sensible, safety-focused legislation. By advocating for mandatory age verification, stringent manufacturing standards and seed sovereignty rather than blunt prohibition, the trade can chart a sustainable path forward—one that protects consumers, preserves retail revenue streams, and defends the agricultural innovators who supply them.

Steven Hoffman is Managing Director of Compass Natural Marketing, a strategic communications and brand development agency serving the natural and organic products industry. Learn more at www.compassnatural.com.

Natural Grocers Wins GMO Labeling Appeal; Supplement Industry Under Pressure

This article first appeared in the February 2026 issue of Presence Marketing’s newsletter.

By Steven Hoffman

In January 2026, the regulatory framework governing the natural products industry encountered significant developments affecting how food and dietary supplements are labeled and regulated. Through a combination of judicial rulings, agency guidance, and legislative proposals, the requirements for transparency and product disclosure are shifting, presenting new compliance considerations for manufacturers and retailers alike.

For CPG brands, ingredient suppliers, and compliance officers, these updates signal a continued move toward explicit, on-package disclosure. Recent events indicate that both the courts and legislators are increasingly prioritizing clear, accessible information for consumers, challenging previous standards that allowed for digital or abbreviated disclosures.

This report outlines two primary developments from the start of the year: the U.S. Court of Appeals ruling in favor of Natural Grocers regarding Bioengineered (BE) disclosures, and a dual-front regulatory discussion involving the FDA and Senator Dick Durbin (D-IL) regarding the dietary supplement sector.

Federal Appeals Court Sides with Natural Grocers in GMO Ruling
In a decision delivered on Jan. 6, 2026, the U.S. Court of Appeals for the Ninth Circuit ruled in favor of a coalition of plaintiffs led by the Lakewood, CO-based retailer Natural Grocers by Vitamin Cottage (NYSE: NGVC) and the Center for Food Safety (CFS). The court’s decision effectively strikes down key portions of the USDA’s Bioengineered Food Disclosure Standard, addressing industry arguments that the previous rules contained exemptions that limited consumer access to information.

The "National Bioengineered Food Disclosure Standard" (NBFDS) has been a subject of debate since its inception. Critics, including the plaintiffs, argued that the USDA’s implementation allowed manufacturers to obscure the presence of genetically modified organisms (GMOs) through the use of digital links and unfamiliar terminology.

According to a Natural Grocers press release, the court’s ruling necessitates a significant revision of USDA rules. The outcome aligns with a long-standing position of Natural Grocers, the nation’s largest family-operated organic and natural grocery retailer, which has prohibited most GMO ingredients in its stores since 2012 and advocated for clearer labeling standards.

The court’s decision focused on three specific areas where the USDA’s previous rules were found to be insufficient or unlawful. Food and beverage manufacturers must now prepare for a regulatory environment that will likely require strategic adjustments in the next rulemaking cycle.

The "Bioengineered" Terminology Battle
First among the court's findings was the rejection of the USDA’s mandate that strictly required the use of the term "bioengineered." Plaintiffs successfully argued that this term is unfamiliar to the average shopper and infringed on free speech rights by prohibiting the use of terms consumers actually understand.

Under the overturned rules, a manufacturer was forced to use "bioengineered" even if their customer base was far more familiar with "GMO" or "Genetically Engineered." According to the Non-GMO Project, recent market research indicates that while 63% of consumers recognize the term "GMO," only 36% are familiar with "bioengineering." By mandating the lesser-known term, the USDA was seen as complicating disclosure. The ruling now paves the way for retailers and brands to use terms that resonate more clearly with their customers, potentially returning the familiar "GMO" acronym to federal disclosures.

Closing the Digital Divide: The End of QR Code Exclusivity
Operationally, a significant aspect of the ruling is the rejection of standalone QR codes as a sufficient means of disclosure. The USDA had previously allowed companies to forgo on-package text disclosures entirely in favor of a scannable code. Natural Grocers and the Center for Food Safety argued that this practice excluded consumers without smartphones, reliable internet access, or technical literacy—demographics that often include the elderly and rural populations.

The court agreed, ruling that companies cannot rely solely on digital disclosures. This decision impacts the "scan to learn more" approach that some large CPG companies had adopted. Brands that utilized digital links to manage label space must now redesign packaging to include clear, on-pack text or symbols accessible to the naked eye.

Highly Processed Ingredients: No More Hiding
Finally, the court found the USDA was incorrect in exempting highly processed foods—such as sugar from sugar beets or oil from canola—simply because the genetic material might not be detectable in the final refined product.

This "highly refined" exemption had been a major point of contention. Natural Grocers argued that even if the DNA is denatured or removed during processing, the ingredient still originates from a bioengineered crop system. The environmental and agricultural impacts remain, regardless of the final chemical structure of the sugar or oil.

"The court’s rejection of the ‘highly refined’ exemption reinforces an important principle: how food is made matters," noted Charlene Guzman, Communications Director of the Non-GMO Project, in a statement to Nosh. Brands that have relied on this exemption should expect closer scrutiny as the USDA revises its rules, particularly for ubiquitous ingredients like oils, sugars, and starches derived from GMO crops.

Heather Isely, Executive Vice President of Natural Grocers, stated that the decision reflects congressional intent. "Congress never intended to require the use of specific terms, the sole use of QR codes, or the exclusion of ingredients made from highly processed GMO crops," she said. "We are pleased the court recognized the shortcomings of the final rule and mandated corrections. Natural Grocers will remain actively engaged in the GMO regulatory process."

George Kimbrell, Legal Director of the Center for Food Safety, added that the ruling ensures consumers will eventually see "clear and accurate GMO label information."

The legal victory is consistent with Natural Grocers' long history of rigorous product standards. Founded in 1955 and with 168 stores across 21 states, the company has utilized a dynamic list—"Things We Won't Carry and Why"—to screen products. As stated in WholeFoods Magazine, if a company cannot verify non-GMO status, Natural Grocers will not stock the item.

The Supplement Industry’s Regulatory Tug-of-War
While the food industry assesses the implications of the GMO ruling, the dietary supplement sector is navigating a complex regulatory landscape. On one hand, the FDA is signaling potential flexibility regarding labeling requirements. On the other, Senator Dick Durbin has reintroduced legislation that could impose new registration requirements.

In a letter to the industry issued on Dec. 11, 2025, the FDA announced it is considering amendments to 21 C.F.R. § 101.93(d). This regulation currently governs the placement of the disclaimer required for structure/function claims under the Dietary Supplement Health and Education Act of 1994 (DSHEA).

Under current rules, supplements making claims such as "Supports heart health" must carry the standard disclaimer: "This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease." Regulations have historically required this disclaimer to appear on every single panel where a claim is made. For small bottles, this often leads to "label clutter," where the same disclaimer is repeated multiple times.

According to the National Law Review, the FDA is looking to remove the "each panel" requirement. Kyle Diamantas, FDA Deputy Commissioner for Human Foods, noted in the letter that revising this regulation would "reduce label clutter and unnecessary costs," aligning with the agency's historical enforcement posture.

Effective immediately, the FDA is exercising "enforcement discretion." The agency will not prioritize penalizing companies that do not repeat the disclaimer on every panel, provided the disclaimer appears at least once and is properly linked to the claims. However, companies should proceed with caution; this is a relaxation of placement frequency, not a removal of the disclaimer itself.

Not all experts view this relaxation as positive. Pieter Cohen, M.D., Associate Professor of Medicine at Harvard Medical School expressed concern to Nutraceutical Business Review, warning that reducing disclaimer visibility could mislead consumers. "Then you start saying things such as, ‘We only need it on the actual bottle.’ Then you let the print get smaller," Cohen noted, highlighting the tension between industry simplification and consumer protection.

Durbin Reintroduces the Dietary Supplement Listing Act
While the FDA offers potential labeling flexibility, Congress is considering increased oversight. On Jan. 17, 2026, Senator Dick Durbin reintroduced the Dietary Supplement Listing Act, aimed at modernizing FDA oversight through Mandatory Product Listing (MPL).

The core of the bill would require manufacturers to register products with the FDA, providing product names, ingredient lists, electronic copies of labels, allergen statements, and structure/function claims. This data would populate a public database accessible to consumers.

Senator Durbin’s argument is rooted in the growth of the sector. When DSHEA passed in 1994, there were approximately 4,000 supplements on the market. Today, the FDA estimates there are over 100,000. Durbin argues that the FDA cannot effectively regulate a market it cannot track. "FDA—and consumers—should know what dietary supplements are on the market and what ingredients are included in them. This is FDA’s most basic function," Durbin stated.

As reported by RiverBender, the bill has garnered endorsements from the American Medical Association, US Pharmacopeia, and Consumer Reports. However, the industry itself remains divided, illustrating a strategic difference between its two major trade associations.

A House Divided: CRN vs. NPA
The reintroduction of the Listing Act has reignited a debate between the Council for Responsible Nutrition (CRN) and the Natural Products Association (NPA).

The CRN supports the legislation, viewing transparency as a path to legitimacy and consumer trust. Steve Mister, President and CEO of CRN, stated, "In an era when the Administration has rightly called for more transparency about what we eat and how food is made, it makes sense to apply that same transparency to dietary supplements." The CRN views the registry as a tool to distinguish legitimate, responsible brands from "fly-by-night" actors selling tainted products, arguing that a federal registry is "a transparency tool—not a barrier to innovation."

Conversely, the NPA opposes the bill. Daniel Fabricant, Ph.D., President and CEO of NPA, characterizes it as unnecessary bureaucracy that burdens lawful companies while failing to stop bad actors. Fabricant argues that DSHEA already gives the FDA ample authority; the agency simply fails to use it.

As detailed in Nutrition Insight, NPA fears that the FDA could use the list to arbitrarily challenge ingredients, citing the recent (and reversed) attempt to ban NMN (nicotinamide mononucleotide) as an example of regulatory overreach. "This proposal will hand bureaucrats new leverage over lawful products, cool innovation, and punish companies investing in new science," Fabricant warned.

Conclusion: The Transparency Mandate
As the year progresses, the common thread connecting the Natural Grocers victory and the Durbin bill is transparency. In the food aisle, the courts have ruled that accessibility is key—labels must be readable without a smartphone and use terms the public understands. In the supplement aisle, the debate continues over whether transparency requires a federal database of every product on the market.

For business leaders, the takeaway is operational agility. Packaging workflows must be adaptable, supply chain documentation must be robust, and regulatory monitoring must be constant. The "clean label" trend is extending beyond ingredients to include the regulatory integrity of the package itself.

Natural Grocers has signaled it will remain active, with executive Heather Isely stating, "Natural Grocers will remain actively engaged in the GMO regulatory process." Brands wishing to remain on the shelves of such high-standard retailers must ensure their transparency efforts meet these rising expectations.

Steven Hoffman is Managing Director of Compass Natural Marketing, a strategic communications and brand development agency serving the natural and organic products industry. Learn more at www.compassnatural.com.